Opioid Induced Constipation Drugs Market USD 2.14 Billion by 2020, Published by iHealthcareAnalyst, Inc.
Maryland Heights, MO, October 29, 2016 --(PR.com)-- The global opioid induced constipation drugs market is estimated to reach USD 2.14 Billion in 2020, growing at a CAGR of 31.3% from 2016 to 2020, according to a market research report Opioid Induced Constipation Drugs Market 2013-2020, published by iHealthcareAnalyst, Inc.
Visit the Opioid Induced Constipation Drugs Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/opioid-induced-constipation-drugs-market/
Opioids are a major class of analgesics and very effective for treating and managing pain. One of the most common side effects of opioids is constipation, also called as opioid-induced - tramadol / hydrocodone / oxycodone / codeine - constipation, or opioid-induced constipation (OIC), which is a symptom in many patients taking these medications.
The global opioid induced constipation drugs market segmentation is based on dosage form of the drug (solid, semi-solid, liquid), and drug classes (Mu opioid receptor antagonist, chloride channel activator).
The global opioid induced constipation drugs market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global opioid induced constipation drugs market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Dosage Form
1.1 Solid Dosage Form
1.2 Semi-solid Dosage Form
1.3 Liquid Dosage Form
2. Drug Class
2.1 Mu Opioid Receptor Antagonist
2.2 Chloride Channel Activator
2.3 Others
3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World
4. Company Profiles
4.1 Abbott Laboratories
4.2 AstraZeneca plc
4.3 Bayer AG
4.4 Boehringer Ingelheim GmbH
4.5 C.B. Fleet Company, Inc.
4.6 COSMO Pharmaceuticals
4.7 Daewoong Pharmaceuticals Co. Ltd.
4.8 Takeda Pharmaceutical Co., Ltd.
4.9 Valiant Pharmaceuticals International, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Visit the Opioid Induced Constipation Drugs Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/opioid-induced-constipation-drugs-market/
Opioids are a major class of analgesics and very effective for treating and managing pain. One of the most common side effects of opioids is constipation, also called as opioid-induced - tramadol / hydrocodone / oxycodone / codeine - constipation, or opioid-induced constipation (OIC), which is a symptom in many patients taking these medications.
The global opioid induced constipation drugs market segmentation is based on dosage form of the drug (solid, semi-solid, liquid), and drug classes (Mu opioid receptor antagonist, chloride channel activator).
The global opioid induced constipation drugs market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global opioid induced constipation drugs market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Dosage Form
1.1 Solid Dosage Form
1.2 Semi-solid Dosage Form
1.3 Liquid Dosage Form
2. Drug Class
2.1 Mu Opioid Receptor Antagonist
2.2 Chloride Channel Activator
2.3 Others
3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World
4. Company Profiles
4.1 Abbott Laboratories
4.2 AstraZeneca plc
4.3 Bayer AG
4.4 Boehringer Ingelheim GmbH
4.5 C.B. Fleet Company, Inc.
4.6 COSMO Pharmaceuticals
4.7 Daewoong Pharmaceuticals Co. Ltd.
4.8 Takeda Pharmaceutical Co., Ltd.
4.9 Valiant Pharmaceuticals International, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories